Luteolin Attenuates Airway Mucus Overproduction Via Inhibition of the GABAergic System

Overview

Journal Sci Rep

Specialty Science

Date 2016 Sep 7

PMID 27595800

Citations 18

Authors

Mei-Lin Shen

Chen-Hung Wang

Ching-Huei Lin

Ning Zhou

Shung-Te Kao

Dong Chuan Wu

Affiliations

Soon will be listed here.

Abstract

Airway mucus overproduction is one of the most common symptoms of asthma that causes severe clinical outcomes in patients. Despite the effectiveness of general asthma therapies, specific treatments that prevent mucus overproduction in asthma patients remain lacking. Recent studies have found that activation of GABAA receptors (GABAAR) is important for promoting mucus oversecretion in lung airway epithelia. Here, we report that luteolin, a natural flavonoid compound, suppresses mucus overproduction by functionally inhibiting the GABAergic system. This hypothesis was investigated by testing the effects of luteolin on goblet cell hyperplasia, excessive mucus secretion, and GABAergic transmission using histological and electrophysiological approaches. Our results showed that 10 mg/kg luteolin significantly decreased the number of goblet cells in the lung tissue and inhibited mucus overproduction in an in vivo asthma model induced by ovalbumin (OVA) in mice. Patch-clamp recordings showed that luteolin inhibited GABAAR-mediated currents in A549 cells. Furthermore, the inhibitory effects of luteolin on OVA-induced goblet cell hyperplasia and mucus overproduction were occluded by the GABAAR antagonist picrotoxin. In conclusion, our observations indicate that luteolin effectively attenuates mucus overproduction at least partially by inhibiting GABAARs, suggesting the potential for therapeutic administration of luteolin in the treatment of mucus overproduction in asthma patients.

Citing Articles

Luteolin: exploring its therapeutic potential and molecular mechanisms in pulmonary diseases.

Lv J, Song X, Luo Z, Huang D, Xiao L, Zou K Front Pharmacol. 2025; 16:1535555.

PMID: 40012626 PMC: 11861102. DOI: 10.3389/fphar.2025.1535555.

Antioxidative and Anticancer Potential of Luteolin: A Comprehensive Approach Against Wide Range of Human Malignancies.

Mahwish , Imran M, Naeem H, Hussain M, Alsagaby S, Al Abdulmonem W Food Sci Nutr. 2025; 13(1):e4682.

PMID: 39830909 PMC: 11742186. DOI: 10.1002/fsn3.4682.

Important functions and molecular mechanisms of aquaporins family on respiratory diseases: potential translational values.

Li J, Yang D, Lin L, Yu L, Chen L, Lu K J Cancer. 2024; 15(18):6073-6085.

PMID: 39440058 PMC: 11493008. DOI: 10.7150/jca.98829.

Uncovering the action mechanism of Shenqi Tiaoshen formula in the treatment of chronic obstructive pulmonary disease through network pharmacology, molecular docking, and experimental verification.

Qinjun Y, Dandan Y, Hui W, Yating G, Xinheng W, Di W J Tradit Chin Med. 2024; 44(4):770-783.

PMID: 39066538 PMC: 11337265. DOI: 10.19852/j.cnki.jtcm.20240610.002.

A 12-week double-blind randomised controlled trial investigating the effect of dietary supplementation with 125 g/d vitamin D in adults with asthma.

Watkins S, Harrison T, Mushtaq S Br J Nutr. 2024; 132(6):738-749.

PMID: 38751303 PMC: 11557293. DOI: 10.1017/S0007114524000953.

References

Zhang X, Zhang R, Zheng Y, Shen J, Xiao D, Li J . Expression of gamma-aminobutyric acid receptors on neoplastic growth and prediction of prognosis in non-small cell lung cancer. J Transl Med. 2013; 11:102. PMC: 3644491. DOI: 10.1186/1479-5876-11-102. View

Vos T, Flaxman A, Naghavi M, Lozano R, Michaud C, Ezzati M . Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2163-96. PMC: 6350784. DOI: 10.1016/S0140-6736(12)61729-2. View

Mittra B, Saha A, Chowdhury A, Pal C, Mandal S, Mukhopadhyay S . Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis. Mol Med. 2000; 6(6):527-41. PMC: 1949962. View

Jin N, Kolliputi N, Gou D, Weng T, Liu L . A novel function of ionotropic gamma-aminobutyric acid receptors involving alveolar fluid homeostasis. J Biol Chem. 2006; 281(47):36012-20. DOI: 10.1074/jbc.M606895200. View

Ordonez C, Khashayar R, Wong H, Ferrando R, Wu R, Hyde D . Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am J Respir Crit Care Med. 2001; 163(2):517-23. DOI: 10.1164/ajrccm.163.2.2004039. View

Hovenberg H, Davies J, Herrmann A, Linden C, Carlstedt I . MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions. Glycoconj J. 1996; 13(5):839-47. DOI: 10.1007/BF00702348. View

Thornton D, Carlstedt I, Howard M, Devine P, Price M, Sheehan J . Respiratory mucins: identification of core proteins and glycoforms. Biochem J. 1996; 316 ( Pt 3):967-75. PMC: 1217443. DOI: 10.1042/bj3160967. View

Singer M, Martin L, Vargaftig B, Park J, Gruber A, Li Y . A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma. Nat Med. 2004; 10(2):193-6. DOI: 10.1038/nm983. View

Satwani H, Rehman A, Ashraf S, Hassan A . Is serum total IgE levels a good predictor of allergies in children?. J Pak Med Assoc. 2009; 59(10):698-702. View

10.

Aikawa T, Shimura S, Sasaki H, Ebina M, Takishima T . Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest. 1992; 101(4):916-21. DOI: 10.1378/chest.101.4.916. View

11.

Das M, Ram A, Ghosh B . Luteolin alleviates bronchoconstriction and airway hyperreactivity in ovalbumin sensitized mice. Inflamm Res. 2003; 52(3):101-6. DOI: 10.1007/s000110300021. View

12.

Huang F, Zhang H, Wu M, Yang H, Kudo M, Peters C . Calcium-activated chloride channel TMEM16A modulates mucin secretion and airway smooth muscle contraction. Proc Natl Acad Sci U S A. 2012; 109(40):16354-9. PMC: 3479591. DOI: 10.1073/pnas.1214596109. View

13.

Wang G, Wang R, Ferris B, Salit J, Strulovici-Barel Y, Hackett N . Smoking-mediated up-regulation of GAD67 expression in the human airway epithelium. Respir Res. 2010; 11:150. PMC: 2988726. DOI: 10.1186/1465-9921-11-150. View

14.

Mizuta K, Osawa Y, Mizuta F, Xu D, Emala C . Functional expression of GABAB receptors in airway epithelium. Am J Respir Cell Mol Biol. 2008; 39(3):296-304. PMC: 2542448. DOI: 10.1165/rcmb.2007-0414OC. View

15.

Henderson Jr W, Banerjee E, Chi E . Differential effects of (S)- and (R)-enantiomers of albuterol in a mouse asthma model. J Allergy Clin Immunol. 2005; 116(2):332-40. DOI: 10.1016/j.jaci.2005.04.013. View

16.

Williams O, Sharafkhaneh A, Kim V, Dickey B, Evans C . Airway mucus: From production to secretion. Am J Respir Cell Mol Biol. 2006; 34(5):527-36. PMC: 2644218. DOI: 10.1165/rcmb.2005-0436SF. View

17.

Xiang Y, Wang S, Liu M, Hirota J, Li J, Ju W . A GABAergic system in airway epithelium is essential for mucus overproduction in asthma. Nat Med. 2007; 13(7):862-7. DOI: 10.1038/nm1604. View

18.

Fu X, Wood K, Spindel E . Prenatal nicotine exposure increases GABA signaling and mucin expression in airway epithelium. Am J Respir Cell Mol Biol. 2010; 44(2):222-9. PMC: 3049233. DOI: 10.1165/rcmb.2010-0109OC. View

19.

Zhou N, Wang C, Zhang S, Wu D . The GLRA1 missense mutation W170S associates lack of Zn2+ potentiation with human hyperekplexia. J Neurosci. 2013; 33(45):17675-81. PMC: 3873627. DOI: 10.1523/JNEUROSCI.3240-13.2013. View

20.

Lai H, Rogers D . New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways. J Aerosol Med Pulm Drug Deliv. 2010; 23(4):219-31. DOI: 10.1089/jamp.2009.0802. View